tirzepatide cv outcomes cardiovascular event risk assessment: a pre-specified meta-analysis SUMMIT: Tirzepatide Improves Outcomes and

However, blood in the liver used in the previous study was not purged

One of the advanced treatments we offer is tirzepatide, a medication approved for the management of type 2 diabetes and, more recently, for weight loss in adults struggling with obesity or excess weight with related health conditions

These findings support the rationale for dual SGLT1/SGLT2 inhibition as a potential therapeutic strategy ( 3.2 Complications and side effects of SGLT2 inhibitors The most common side effect of SGLT-2 inhibitors is polyuria, resulting from osmotic diuresis

Adequate fluid intake helps prevent dehydration, which can be mistaken for hunger, and helps manage constipationa common side effect